Aurobindo Pharma reported INR120.53B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Cipla INR 65.97B 4.37B Mar/2026
Divis Laboratories Ltd INR 39.54B 7.18B Mar/2026
Dr.Reddys Laboratories INR 80.47B 3.94B Jun/2026
Hindustan Unilever INR 47.89B 3.01B Mar/2026
Sun Pharmaceuticals INR 114.93B 12.5B Mar/2026
UPL INR 126.76B 35.17B Mar/2026